can’t sell in US it seems?
couldn’t sell oversees due to the lack of appropriate certification?
now seem to be making strategic decisions from a position of weakness diluting shareholder interest once again
$150m in debt and want to take out another loan for US$700m ARE YOU KIDDING ME
unless it is seen that your sales revenue has ramped up 10 fold in the next annual report, this will collapse and take all its shareholders with it
They say they will report material issues. Well it starts today! Tell us about your actual sales and future contracted sales
otherwise this will likely head to LOCK UP pretty soon
- Forums
- ASX - By Stock
- MNS
- Ann: ASIC Supplementary Submission to Senate Inquiry
Ann: ASIC Supplementary Submission to Senate Inquiry, page-114
-
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online